What Do You Need to Know about Osteomyelitis of the Jaws?

You must log in to register
- Member - $50
- Resident Member - Free!
- Allied Staff Member - $50
- Professional Staff Nonmember - $100
- Other Nonmember - $100
Continue

Despite many advances in diagnosis and treatment, osteomyelitis of the jaws still presents a significant challenge to oral and maxillofacial surgeons. The disease management is complicated with the development of resistant microorganisms and the improper initial management by different specialties. Oral and maxillofacial surgeons play a significant role in the surgical management of osteomyelitis. This session will discuss the pathogenesis of osteomyelitis of the jaws and explain the current classification system of the disease. The disease's medical and surgical treatments and recent advances in diagnosis and surgical planning also will be presented.

Learning Objectives

At the conclusion of this program, participants should be able to:

Discuss the pathophysiology of osteomyelitis.
Explain the current classification of jaw osteomyelitis and the appropriate treatment for each class.
Review the different types of imaging, including nuclear medicine, and the best modality to help in early diagnosis and management.
Explain the different available antibiotics and the best route of administration.
Describe the role of the OMS in the management of the disease and the challenges associated with the reconstruction of the defects after osteomyelitis.

Dina Amin, DDS, FACS
Assistant Professor
Emory University
Atlanta, Georgia
Disclosure: Nothing to disclose.

Hisham A. Marwan, DDS, FACS
Assistant Professor
University of Texas Medical Branch
Galveston, Texas
Disclosure: Nothing to disclose.

An Internet-based CDE/CME Activity
Original Release Date: October 1, 2021
Last Review Date: April 20, 2024
Expiration Date: April 20, 2027
Estimated time to complete this educational activity: 1.0 hours
Method of participation: Self-Study

Dina Amin, DDS, FACS

OMFS Program Director

University of Rochester

Dr. Dina Amin is an Associate Professor and the Residency Program Director in the Department of Oral and Maxillofacial Surgery at the University of
Rochester, Rochester, NY. She specializes in oral, head, and neck oncology and microvascular reconstructive surgery. She graduated from King
Abdulaziz University, the only internationally accredited dental school by the Commission on Dental Accreditation (CODA). She completed a
Oral and Maxillofacial Surgery residency in Saudi Arabia, followed by fellowships in craniofacial surgery, head and neck oncology, and
microvascular reconstructive surgery at the University of Alabama at Birmingham (UAB), Birmingham, Alabama, US. Dr. Amin joined the Emory
Division of Oral and Maxillofacial Surgery (OMS) in 2016 as the director of the OMS Ambulatory Clinic. In 2021, she was appointed the associate
chief of OMS service at Grady Memorial Hospital, Atlanta, GA. Dr. Amin is accredited with introducing head and neck oncology and microvascular
reconstruction, utilizing computer-assisted surgery and computer-assisted navigation to complex craniomaxillofacial trauma and advanced head and
neck reconstruction to the clinical services of Emory OMS. Dr. Amin worked briefly at Texas A&M University and Baylor Medical Center before
joining the University of Rochester. Her primary research evolved from her interests in craniomaxillofacial trauma and head and neck reconstruction, as she is the PI of an orbital trauma clinical trial. Dr. Amin has received intramural and international grants. She is the author of more than 30 articles in peer-reviewed journals and 15 book chapters. She also edited one book entitled" Pitfalls and Pearls in Oral and Maxillofacial Surgery."

Disclosure(s): No financial relationships to disclose

Hisham A. Marwan, DDS, FACS

Associate Professor, Division Chief

University of Texas Medical Branch

Dr. Marwan is an associate professor of surgery and the division chief at the University of Texas Medical Branch. Dr. Marwan completed his postdoctoral training in oral and maxillofacial surgery at the University of Miami/ Jackson Memorial Hospital. He then completed two years of fellowship training in Head and Neck Oncology and Microvascular Surgery. In 2018, he joined the faculty at the University of Texas Medical Branch at Galveston. Dr. Marwan is double board certified in oral and maxillofacial surgery, oral, head and neck oncology, and microvascular surgery. Dr. Marwan has authored several manuscripts in Head and Neck Oncology, reconstruction, and craniomaxillofacial trauma. In addition, he wrote and edited multiple book chapters on CMF and maxillofacial surgery.

Disclosure: Nothing to disclose

Continuing Education Provider Approval
The American Association of Oral and Maxillofacial Surgeons is an ADA CERP Recognized Provider.

ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education.

ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.

The American Association of Oral and Maxillofacial Surgeons designates this activity for 1.0 continuing education credit(s).

AGD - Accepted Program Provider
FAGD/MAGD Credit
11/1/22-12/31/26
Provider ID# 214680

The American Association of Oral and Maxillofacial Surgeons (AAOMS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Oral and Maxillofacial Surgeons designates this internet-based enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Key:

Complete

Failed

Available

Locked

Faculty and Planner Disclosure